Artykuły w czasopismach na temat „Anti-IL-17”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Anti-IL-17”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Ly, Karen, Mary P. Smith, Quinn Thibodeaux, Vidhatha Reddy, Wilson Liao, and Tina Bhutani. "Anti IL-17 in psoriasis." Expert Review of Clinical Immunology 15, no. 11 (2019): 1185–94. http://dx.doi.org/10.1080/1744666x.2020.1679625.
Pełny tekst źródłaBuckland, Jenny. "Anti-TNF and anti-IL-17 antibodies—better together!" Nature Reviews Rheumatology 10, no. 12 (2014): 699. http://dx.doi.org/10.1038/nrrheum.2014.183.
Pełny tekst źródłaDaude, M., and S. Barbarot. "Maladie de Darier et anti IL 17." Annales de Dermatologie et de Vénéréologie - FMC 3, no. 8 (2023): A282. http://dx.doi.org/10.1016/j.fander.2023.09.448.
Pełny tekst źródłaNdongo-Thiam, Ndieme, Alice Clement, Jean-Jacques Pin, Diane Razanajaona-Doll, and Pierre Miossec. "Negative association between autoantibodies against IL-17, IL-17/anti-IL-17 antibody immune complexes and destruction in rheumatoid arthritis." Annals of the Rheumatic Diseases 75, no. 7 (2016): 1420–22. http://dx.doi.org/10.1136/annrheumdis-2016-209149.
Pełny tekst źródłaSales-Campos, Helioswilton, Chamberttan Souza Desidério, Rafael Obata Trevisan, et al. "Anti-IL-4, Anti-IL-17, and Anti-IFN-Gamma Activity in the Saliva of Amblyomma sculptum Ticks." International Journal of Molecular Sciences 26, no. 10 (2025): 4734. https://doi.org/10.3390/ijms26104734.
Pełny tekst źródłaSelimov, Pavel, Rositsa Karalilova, Ljubinka Damjanovska, et al. "Rheumatoid arthritis and the proinflammatory cytokine IL-17." Folia Medica 65, no. 1 (2023): 53–59. http://dx.doi.org/10.3897/folmed.65.e72448.
Pełny tekst źródłaBurchill, Matthew A., Dean T. Nardelli, Douglas M. England, et al. "Inhibition of Interleukin-17 Prevents the Development of Arthritis in Vaccinated Mice Challenged with Borrelia burgdorferi." Infection and Immunity 71, no. 6 (2003): 3437–42. http://dx.doi.org/10.1128/iai.71.6.3437-3442.2003.
Pełny tekst źródłaManiati, Eleni, and Thorsten Hagemann. "IL-17 mediates resistance to anti-VEGF therapy." Nature Medicine 19, no. 9 (2013): 1092–94. http://dx.doi.org/10.1038/nm.3333.
Pełny tekst źródłaLux, Sebastian. "Psoriasis: Anti-IL-17-Inhibitor als Rescue-Therapie?" hautnah dermatologie 35, no. 2 (2019): 30. http://dx.doi.org/10.1007/s15012-019-3036-2.
Pełny tekst źródłaCooper, Andrea M. "IL-17 and anti-bacterial immunity: Protectionversustissue damage." European Journal of Immunology 39, no. 3 (2009): 649–52. http://dx.doi.org/10.1002/eji.200839090.
Pełny tekst źródłaWendling, Daniel, Clément Prati, Mickael Chouk, and Frank Verhoeven. "Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism?" Joint Bone Spine 87, no. 1 (2020): 5–7. http://dx.doi.org/10.1016/j.jbspin.2019.06.012.
Pełny tekst źródłaSato, Shuzo, Xian Zhang, Haruki Matsumoto, et al. "Transcription factor Fli-1 impacts IL-17 expression and affects immune cell infiltration into the kidney in lupus-prone mice." Journal of Immunology 204, no. 1_Supplement (2020): 59.15. http://dx.doi.org/10.4049/jimmunol.204.supp.59.15.
Pełny tekst źródłaHamada, Kaoru, Yu Sawada, Ryosuke Hino, and Motonobu Nakamura. "HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17." Australasian Journal of Dermatology 59, no. 2 (2017): e154-e154. http://dx.doi.org/10.1111/ajd.12701.
Pełny tekst źródłaLee, Hajeong, Jae Wook Lee, Kyung Don Yoo, et al. "Cln 3-requiring 9 is a negative regulator of Th17 pathway-driven inflammation in anti-glomerular basement membrane glomerulonephritis." American Journal of Physiology-Renal Physiology 311, no. 3 (2016): F505—F519. http://dx.doi.org/10.1152/ajprenal.00533.2015.
Pełny tekst źródłaIndah Jayanthi, Anak Agung, Luh Made Mas Rusyati, Ni Made Dwi Puspawati, I. Gusti Ayu Agung Elis Indira, I. Gusti Nyoman Darmaputra, and I. Gusti Ayu Agung Dwi Karmila. "Kadar interleukin-17 plasma berkorelasi positif dengan kadar imunoglobulin M (IgM) anti phenolic glycolipid-1 (PGL-1) pada narakontak serumah pasien kusta tipe multibasiler." Intisari Sains Medis 14, no. 1 (2023): 445–51. http://dx.doi.org/10.15562/ism.v14i1.1694.
Pełny tekst źródłaSiloşi, Isabela, Mihail Virgil Boldeanu, Manole Cojocaru, et al. "The Relationship of Cytokines IL-13 and IL-17 with Autoantibodies Profile in Early Rheumatoid Arthritis." Journal of Immunology Research 2016 (2016): 1–10. http://dx.doi.org/10.1155/2016/3109135.
Pełny tekst źródłaCho, Mila, Seon-Yeong Lee, Jin-Sil Park, et al. "Up-Regulation of Stromal Cell-Derived Factor by IL-17 and IL-18 via Phosphatidylinositol 3-Kinase Dependent Pathway (171.8)." Journal of Immunology 188, no. 1_Supplement (2012): 171.8. http://dx.doi.org/10.4049/jimmunol.188.supp.171.8.
Pełny tekst źródłaGarber, Ken. "Anti-IL-17 mAbs herald new options in psoriasis." Nature Biotechnology 30, no. 6 (2012): 475–76. http://dx.doi.org/10.1038/nbt0612-475.
Pełny tekst źródłaZelante, Teresa, Antonella De Luca, Carmen D' Angelo, Silvia Moretti, and Luigina Romani. "IL-17/Th17 in anti-fungal immunity: What's new?" European Journal of Immunology 39, no. 3 (2009): 645–48. http://dx.doi.org/10.1002/eji.200839102.
Pełny tekst źródłaHölttä, Veera, Taina Sipponen, Mia Westerholm-Ormio та ін. "In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells". ISRN Gastroenterology 2012 (14 червня 2012): 1–6. http://dx.doi.org/10.5402/2012/505432.
Pełny tekst źródłaMiyagawa, Hanae, Hiromichi Hara, Jun Araya, et al. "Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis." PLOS ONE 16, no. 1 (2021): e0245284. http://dx.doi.org/10.1371/journal.pone.0245284.
Pełny tekst źródłaFrieder, Jillian, Dario Kivelevitch, Isabel Haugh, Ian Watson, and Alan Menter. "Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory Conditions." Clinical Pharmacology & Therapeutics 103, no. 1 (2017): 88–101. http://dx.doi.org/10.1002/cpt.893.
Pełny tekst źródłaZuniga, Luis, Wen-Jun Shen, Barbara Joyce-Shaikh, et al. "IL-17 — a novel adipose tissue cytokine with anti-adipogenic and pro-osteogenic properties (114.6)." Journal of Immunology 186, no. 1_Supplement (2011): 114.6. http://dx.doi.org/10.4049/jimmunol.186.supp.114.6.
Pełny tekst źródłaCHIBA, Kenji. "A new orally active anti-rheumatic drug targets IL-15 and IL-17." Japanese Journal of Clinical Immunology 30, no. 5 (2007): 375–82. http://dx.doi.org/10.2177/jsci.30.375.
Pełny tekst źródłaSheet, Madha Mohammed, Laith Abdul-Elah Kamel та Jamal Nasser Farhood. "The Role of Anti-TNFα Therapy in the Amelioration of Disease Burden in Patients with Refractory Rheumatoid Arthritis". Al Mustansiriyah Journal of Pharmaceutical Sciences 14, № 1 (2014): 14–22. http://dx.doi.org/10.32947/ajps.v14i1.121.
Pełny tekst źródłaXu, Jiangnan, Yamei Zhang, Jordi Ochando, Liwu Li, and Yaozhong Ding. "IL-17 plays a critical role in airway epithelial injury after transplantation." Journal of Immunology 198, no. 1_Supplement (2017): 82.24. http://dx.doi.org/10.4049/jimmunol.198.supp.82.24.
Pełny tekst źródłaMou, Zhirong, Ping Jia, Shiby Kuriakose, Forough Khadem, and Jude E. Uzonna. "Interleukin-17-Mediated Control of Parasitemia in Experimental Trypanosoma congolense Infection in Mice." Infection and Immunity 78, no. 12 (2010): 5271–79. http://dx.doi.org/10.1128/iai.00168-10.
Pełny tekst źródłaKuroi, Taiga, Sachiyo Okamoto, Kyosuke Saeki та ін. "Anti-IL-12/23 p40 Antibody Attenuates Chronic Graft Versus Host Disease Via Suppression of IFN-γ/IL-17-Producing Cells". Blood 124, № 21 (2014): 1095. http://dx.doi.org/10.1182/blood.v124.21.1095.1095.
Pełny tekst źródłaGargiulo, Luigi, Luciano Ibba, Alessandra Narcisi, et al. "Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study." Dermatology Practical & Conceptual 14, no. 4 (2024): e2024250. http://dx.doi.org/10.5826/dpc.1404a250.
Pełny tekst źródłaVelden, Joachim, Hans-Joachim Paust, Elion Hoxha, et al. "Renal IL-17 expression in human ANCA-associated glomerulonephritis." American Journal of Physiology-Renal Physiology 302, no. 12 (2012): F1663—F1673. http://dx.doi.org/10.1152/ajprenal.00683.2011.
Pełny tekst źródłaCaspi, Rachel, Phyllis Silver, Daniel Cua, Zoe Chen, Chi-Chao Chan, and Dror Luger. "IL-23 and IL-17 in pathogenesis of experimental ocular autoimmunity: requirement for IL–23 may extend beyond its role in sustaining the IL-17 effector response (129.26)." Journal of Immunology 178, no. 1_Supplement (2007): S222. http://dx.doi.org/10.4049/jimmunol.178.supp.129.26.
Pełny tekst źródłaChai, Lichao, Jing Wang, and Yan Wei. "Fucoxanthin improves functional recovery of orbitopathy in Graves’ disease by downregulating IL-17 mRNA expression in a mouse model." Tropical Journal of Pharmaceutical Research 19, no. 5 (2020): 933–41. http://dx.doi.org/10.4314/tjpr.v19i5.4.
Pełny tekst źródłaChabaud, Martine, François Fossiez, Jean-Luc Taupin, and Pierre Miossec. "Enhancing Effect of IL-17 on IL-1-Induced IL-6 and Leukemia Inhibitory Factor Production by Rheumatoid Arthritis Synoviocytes and Its Regulation by Th2 Cytokines." Journal of Immunology 161, no. 1 (1998): 409–14. http://dx.doi.org/10.4049/jimmunol.161.1.409.
Pełny tekst źródłaAmlong, Corey A., Dean T. Nardelli, Sara Heil Peterson, Thomas F. Warner, Steven M. Callister, and Ronald F. Schell. "Anti-Interleukin-15 Prevents Arthritis in Borrelia-Vaccinated and -Infected Mice." Clinical and Vaccine Immunology 13, no. 2 (2006): 289–96. http://dx.doi.org/10.1128/cvi.13.2.289-296.2006.
Pełny tekst źródłaMisra, Durga Prasanna, Smriti Chaurasia, and Ramnath Misra. "Increased Circulating Th17 Cells, Serum IL-17A, and IL-23 in Takayasu Arteritis." Autoimmune Diseases 2016 (2016): 1–8. http://dx.doi.org/10.1155/2016/7841718.
Pełny tekst źródłaPitmon, Elise V., Ju Chen, Xiaoyang Ye, and Kepeng Wang. "A Direct Link between IL-17 and Regulatory T cells in Autoimmune Colitis." Journal of Immunology 204, no. 1_Supplement (2020): 143.17. http://dx.doi.org/10.4049/jimmunol.204.supp.143.17.
Pełny tekst źródłaJosé, Anthar Ávalos Narváez, Daniel Solís Dittrich Kevin, Elisa González Robles María, Jiménez Zaragoza Michelle, Arturo Ovilla Alvarez Ricardo, and Aréchiga López Mayra. "Advances in Monoclonal Antibody Therapy for Moderate to Severe Psoriasis: Targeting TNF, IL-17, And IL-23 Pathways for Optimal Disease Management." International Journal of Medical Science and Clinical Research Studies 5, no. 05 (2025): 766–69. https://doi.org/10.5281/zenodo.15502235.
Pełny tekst źródłaAtzeni, Fabiola, Antonio Carriero, Laura Boccassini, and Salvatore D'Angelo. "Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis." ImmunoTargets and Therapy Volume 10 (May 2021): 141–53. http://dx.doi.org/10.2147/itt.s259126.
Pełny tekst źródłaKe, Yan, Ke Liu, Guo-Qiang Huang, et al. "Anti-Inflammatory Role of IL-17 in Experimental Autoimmune Uveitis." Journal of Immunology 182, no. 5 (2009): 3183–90. http://dx.doi.org/10.4049/jimmunol.0802487.
Pełny tekst źródłaPuig, L. "Brodalumab: The first anti-IL-17 receptor agent for psoriasis." Drugs of Today 53, no. 5 (2017): 283. http://dx.doi.org/10.1358/dot.2017.53.5.2613690.
Pełny tekst źródłaNoell, Claire, Brianna McQuade, Alice Gottlieb, and David Rosmarin. "Anti IL-17 flared psoriasis in a patient on secukinumab." Dermatologic Therapy 30, no. 4 (2017): e12505. http://dx.doi.org/10.1111/dth.12505.
Pełny tekst źródłaZhang, Rui, Jiang Qian, Jie Guo, Yi-fei Yuan, and Kang Xue. "Suppression of Experimental Autoimmune Uveoretinitis by Anti-IL-17 Antibody." Current Eye Research 34, no. 4 (2009): 297–303. http://dx.doi.org/10.1080/02713680902741696.
Pełny tekst źródłaBrown, Gabrielle, Mona Malakouti, Eva Wang, John Y. Koo, and Ethan Levin. "Anti-IL-17 phase II data for psoriasis: A review." Journal of Dermatological Treatment 26, no. 1 (2014): 32–36. http://dx.doi.org/10.3109/09546634.2013.878448.
Pełny tekst źródłaEl-Lessy, Fatma. "Downregulation of proinflammatory cytokines and dynamic expression of TGF-β1 molecules induced by anti-IL-17 mAb in murine schistosomiasis mansoni". Egyptian journal of Immunology 32, № 1 (2025): 16–26. https://doi.org/10.55133/eji.320102.
Pełny tekst źródłaBanuelos, Jesus, Soon Shin, and Nick Lu. "Distinct glucocorticoid sensitivity of Th17 cytokines in murine T hybridomas and primary cells (IRC11P.428)." Journal of Immunology 194, no. 1_Supplement (2015): 197.10. http://dx.doi.org/10.4049/jimmunol.194.supp.197.10.
Pełny tekst źródłaPrabhala, Rao H., Mariateresa Fulcinitti, Dheeraj Pelluru, et al. "Multiple Myeloma Cells Express IL-17A Creating An Autocrine Loop: An Attractive Therapeutic Target." Blood 122, no. 21 (2013): 3113. http://dx.doi.org/10.1182/blood.v122.21.3113.3113.
Pełny tekst źródłaFried, Richard, Mark Lebwohl, Miriam Bettencourt, John Koo, and Abby Jacobson. "Onset of Plaque Psoriasis Treatment Responses With Anti-IL-17/IL-23 Biologic Therapies." Journal of Drugs in Dermatology 21, no. 8 (2022): 854–60. http://dx.doi.org/10.36849/jdd.66791.
Pełny tekst źródłaMatusiak, Łukasz, Justyna Szczęch, Andrzej Bieniek, Danuta Nowicka-Suszko, and Jacek C. Szepietowski. "Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents." Journal of the American Academy of Dermatology 76, no. 4 (2017): 670–75. http://dx.doi.org/10.1016/j.jaad.2016.10.042.
Pełny tekst źródłaYin, Yuanqin, Fei Li, Jing Shi, Songlin Li, Jingjing Cai, and Youhong Jiang. "MiR-146a Regulates Inflammatory Infiltration by Macrophages in Polymyositis/Dermatomyositis by Targeting TRAF6 and Affecting IL-17/ICAM-1 Pathway." Cellular Physiology and Biochemistry 40, no. 3-4 (2016): 486–98. http://dx.doi.org/10.1159/000452563.
Pełny tekst źródłaEl-Zawawy, Hanaa Tarek, Huda Fahmy Farag, Mona Mohamed Tolba, and Hanaa Abdalbasit Abdalsamea. "Improving Hashimoto’s thyroiditis by eradicating Blastocystis hominis: Relation to IL-17." Therapeutic Advances in Endocrinology and Metabolism 11 (January 2020): 204201882090701. http://dx.doi.org/10.1177/2042018820907013.
Pełny tekst źródła